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Determining the Effects of Psychosocial Interventions on Quality of Life for 
Cancer Patients: Analysis of Pilot Data and Recommendations for Full 
Experimental Design and Statistical Analysis 
 
 
Introduction 
 Anxiety, depression, and other symptoms of psychological stress are 
generally observed to be increased in patients diagnosed with cancer [1-4].  
Attempts to alleviate these adverse consequences to quality of life experienced by 
cancer patients have led to the development of various psychological and 
psychosocial interventions, or “wellness” programs.  One popular approach is 
called mindful meditation or mindfulness based stress reduction; in fact, Carlson 
et al.(2003) reported that there were over 240 such programs in North America 
[3].  The successful completion of a meditation program has been associated with 
improvements in quality of life, as measured by multiple psychometric scales, 
such as the European Organization for Research and Treatment of Cancer Quality 
of Life Questionnaire (EORTC QLQ-C30), the Profile of Mood States (POMS), 
Symptoms of Stress Inventory (SOSI) [5,6].  Similar benefit has also been seen in 
cancer patients who participate in yoga programs or who study yoga 
independently [6].  Aside from meditation, yoga, and other nontraditional 
wellness programs, more conventional psychological counseling programs are 
widely offered to oncology patients.  Data in the literature suggest that a variety 
of wellness interventions is capable of leading to stress reduction in cancer 
patients, even for those patients receiving chemotherapy at the time [7].   
Newell et al.(2002) noted in a review of the literature that over 600 papers 
have been published concerning the evaluation of psychological therapies for 
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cancer patients [8].  The papers reviewed by Newell et al. spanned many types of 
psychosocial programs, such as traditional counseling, cancer education, 
meditation, hypnosis, and music therapy; many forms of intervention 
administration, such as individual sessions, group sessions, and audiotape; and a 
wide range of targeted effects, such as decreased stress, hostility, depression, and 
anxiety, or improved immune response and overall quality of life.  Although each 
study tended to give positive reports on the benefits of psychosocial interventions 
for cancer patients, Newell et al. were hesitant to acknowledge most of the reports 
as statistically significant, due to serious methodological deficiencies (see 
Recommendations for Experimental Design below) in many of the studies 
reviewed [8].  Obviously, there is still some debate in the medical world as to the 
actual utility of these types of wellness programs [8,9].   
The popular press has always been keen to report any news associated 
with cancer research, and the use of psychosocial or other nontraditional therapies 
is no exception [10,11].  Typically, these reports tend to focus on small numbers 
of individuals who have experienced miraculous results, for instance, the long-
term remission of cancer thought to be incurable by physicians after the patient 
had practiced rigorous meditation.  These media reports must be viewed as purely 
anecdotal and are no basis for scientific proof that psychological therapies can 
“cure” cancer; however, these stories can be encouraging for individuals suffering 
the physical and psychological effects of cancer and cancer treatments, and 
patients are increasingly willing to enroll in psychosocial self-help programs 
[10,11].   
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The Hematology and Oncology Specialists Foundation was established in 
2001 with the mission to improve the quality of life for the patients being treated 
by HOS physicians, and to provide the services for this purpose at no cost to the 
patient.  Current services include: a mindful meditation group program, a yoga 
group program, personal psychological counseling, financial counseling and 
assistance, nutritional counseling, lymph edema management, and genetic 
counseling.  See page A2 for full descriptions of these wellness programs.  Since 
the inception of the HOS Foundation, 351 cancer patients have participated in one 
of the available wellness programs, and each year, the Foundation continues to 
increase its budget for these programs  The HOS Foundation has found that 
patients report considerable improvement in well-being after participating in 
every one of the available wellness interventions, and that evidence of 
improvement in quality of life can be observed with proper psychometric 
instruments.  In light of these encouraging signs, the HOS Foundation now seeks 
to evaluate the effect of the Foundation’s psychosocial intervention programs on 
the quality of life of HOS patients in an objective, scientific manner [12].   
 
Study Objectives 
 The goal of this pilot study by the HOS Foundation is to collect some 
exploratory data from the patients currently participating in the wellness 
intervention programs offered by the Foundation; this data will hopefully support 
the hypothesis that participation in these programs helps to improve the overall 
quality of life experienced by cancer patients.  The ultimate goal for the HOS 
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Foundation is to publish the results of a large-scale study of the benefits of the 
wellness intervention programs in a prestigious oncology journal.  The HOS 
Foundation will have to seek financial support outside its own resources in order 
to fund a large-scale implementation of these wellness programs, to complete a 
comprehensive study of the effects of the programs, and to subsequently publish 
an article with the results of the study [12].  Pilot data are useful when designing 
an experiment because the parameters of the sample, such as mean and standard 
deviation, can be used as estimates for the true population parameters.  Most 
notably, these estimates can be used to determine the ideal sample size for the 
full-scale experiment, without having to actually sample a large number of 
patients.  The results from the exploratory data can then be included in proposals 
to obtain the necessary financial assistance.   
 In the initial study protocols developed by the Foundation for the Yoga, 
Meditation, and Counseling Interventions, the primary endpoint is identified as 
determining the overall change in quality of life by using the EORTC QLQ-C30.  
Some secondary endpoints are to determine the overall change in emotional well-
being by using the Beck Anxiety Inventory (BAI) and Beck Depression Inventory 
(BDI-II) questionnaires, to evaluate the effectiveness of the wellness programs by 
using an internally developed patient survey, to identify the primary reasons why 
cancer patients seek participation in wellness programs, and to identify the impact 
of intervention on medical treatment for cancer, compared to planned treatment 
duration.  The Foundation is interested in determining the mean percent change in 
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quality of life and emotional well-being for the entire patient sample and for the 
sample stratified by disease state.   
 
Pilot Data 
 The data collected in this pilot study are the sole property of the HOS 
Foundation and are intended for internal use only.  The author’s access to this 
data is allowed only in the capacity as a statistical advisor for the HOS 
Foundation; therefore, the actual data set cannot be included with this paper.  
Relevant descriptive statistics and statistical analyses are summarized below.   
 Eleven patients completed Beck Stress Related Symptoms (BSRS) surveys 
both prior to participation in, and after completion of, an eight-week mindful 
meditation program offered by the HOS Foundation.  The mean score prior to 
participation (BSRS pre-score) was 112.7, with a standard deviation of 43.7.  The 
mean score after completion of the program (BSRS post-score) was 85.4, with a 
standard deviation of 33.5.  The variable BSRS change, defined as BSRS pre-
score minus BSRS post-score, has a mean of 27.4 and a standard deviation of 
33.7.   
Six patients completed BAI and BDI-II questionnaires both prior to 
participation in, and after completing a twelve-week counseling program offered 
by the Foundation.  The mean BAI pre-score was 25.17, with a standard deviation 
of 12.12; the mean BAI post-score was 9.33, with a standard deviation of 6.62.  
The variable BAI change, defined as BAI pre-score minus BAI post-score, has a 
mean of 15.83 and standard deviation of 7.28.  The mean BDI-II pre-score was 
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18.67, with a standard deviation of 6.59.  The mean BDI-II post-score was 7.67, 
with a standard deviation of 6.31, and the variable BDI-II change, defined as BDI-
II pre-score minus BDI-II post-score, has a mean of 11.0 and a standard deviation 
of 3.1.  See page B1 for summary charts of descriptive statistics.   
 
Analysis 
 All statistical analyses for this study were conducted with Minitab® 
Release 14 Statistical Software for Windows.  The significance level (α) used 
throughout this paper is α = 0.05.   
 
Results 
 To test whether or not participation in the meditation program had an 
effect on BSRS scores, a one-sample t-test was used to test if the BSRS change 
variable is significantly different from zero.  The researchers are interested in 
showing whether participation in these wellness program provides a benefit to 
patients, so in this case, it is logical to conduct a one-tailed t-test to test the 
alternate hypothesis that the mean of the BSRS change score is greater than zero.  
The t-score for this test is t = 2.70 (p = 0.011).  Thus, the null hypothesis that the 
mean BSRS change is equal to or less than zero can be rejected, and it can be 
concluded that the true BSRS change mean is significantly greater than zero.  A 
post hoc power analysis revealed that this one-tailed test has a power of 0.806 to 
detect a difference of 27.4, assuming a standard deviation of 33.7 and using a 
sample size of 11.  This is a surprisingly high power for a small sample size.  
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Therefore, it is reasonable to conclude that participation in the meditation 
intervention decreased the patients’ scores on the BSRS survey.   
 The same procedure can be used to test if the BAI change and BDI-II 
change scores are significantly greater than zero for the counseling intervention 
program; again, a one-tailed test was used in each instance.  The t-score to test 
whether BAI change is greater than zero is t = 5.33 (p = 0.002); therefore, the null 
hypothesis that BAI change is equal to or less than zero can be rejected.  A post 
hoc power analysis revealed a power of 0.997, which of course is very high.  The 
t-score to test if BDI-II change is greater than zero is t = 8.70 (p < 0.001), so 
again, the null hypothesis that BDI-II change is equal to or less than zero can be 
safely rejected.  A power analysis revealed an extremely high power > 0.999.  
Thus, it is quite reasonable to conclude that participation in the counseling 
program reduced patients’ scores on the BAI and BDI-II questionnaires.  See page 
B1 for a summary of hypotheses tests.   
 The researchers should also be interested to see if the pilot data show any 
differences between effectiveness of the wellness interventions, as this is one of 
the questions they want to explore in the full-scale study.  Unfortunately, for this 
pilot study, the two groups of patients completed different psychometric surveys, 
thus making it difficult to make any comparisons.  Notice that patients enrolled in 
the meditation program improved their BSRS scores by an average of 24.3%, and 
that patients enrolled in the counseling program improved their BAI scored by an 
average of 62.8% and BDI-II scores by an average of 58.9%.  However, 
comparing the mean percent changes in psychometric survey scores between 
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groups would not be very meaningful, as one survey measured stress levels, one 
measured anxiety levels, and the other measured depression levels.   
 
Recommendations for Experimental Design 
 There are several methodological deficiencies evident regarding the 
original study schemas and the collection of the pilot data.  The most glaring fault 
is the small size of the samples; the researchers were very fortunate to have 
obtained any significant results from such a small sample.  In order to assure that 
a large-scale study will also yield significant results, if in fact the results truly 
should be significant, the sample size needs to be considered carefully.  
Determining the appropriate sample size for a one-sample t-test is fairly 
straightforward; all the researchers need to do is decide how much of a decrease 
in stress or anxiety or depression scores is medically significant, and, given an 
estimate of variability within the population, a power analysis will give the 
sample size necessary for the same decrease to be statistically significant as well.  
However, when trying to determine the appropriate sample sizes for more 
complicated statistical procedures such as ANOVA, several other serious 
methodological problems become evident.  See page B2 for tables of powers and 
sample sizes for one-tailed one-sample t-tests.  See pages B3-B4 for a discussion 
on interpreting the meaning of power.   
 There was unnecessary and counterproductive variation regarding the 
administration of the different treatments and psychometric tools used in the pilot 
study.  The patients in the meditation group and the patients in the counseling 
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group completed different sets of psychometric questionnaires; therefore, it was 
impossible to compare the change in quality of life between the two groups.  The 
researchers are interested in whether meditation, yoga, or some other type of 
nontraditional therapy improves the quality of life for cancer patients to a 
different degree than a traditional psychological counseling program.  In order to 
do this, the same measurement tool must be used for all treatment groups.  If 
participation in these wellness programs really does have an effect on quality of 
life, then the data will show this, no matter which set of psychometric surveys is 
employed, for each of these surveys is widely accepted in psychological and 
medical research to be a credible and accurate indicator of psychological states.   
Also, the pilot schema called for a 12-week program that met once a week 
for counseling and yoga, while the meditation program met twice a week for 8 
weeks.  In order to compare the effects of one program with the effects of another, 
it is important for the administration of treatments to be as homogenous as 
possible.  For example, if participation in the meditation group results in a greater 
reduction in stress, it is possible that the full effect is not a result of the meditation 
itself, but that any intervention program that met twice a week versus once a week 
would have an effect similar to the meditation program.  When setting up a 
scientific experiment that is intended to show the effect of one variable on 
another, it is very important to control and standardize all the other factors that 
may also have an effect on the response variable.  Factors that cannot be 
completely controlled must either be completely randomized, or measured and 
tested for any effects on the response variable, as in the instance of covariates.   
 10 
Finally, Newell et al.(2002) noted that a very important consideration 
absent from many studies of this nature is the inclusion of a control group [8].  It 
is important to have a control group to account for any natural time trends, for it is 
reasonable to expect that patients not participating in any intervention programs 
may experience some change in their mood or stress levels over a period of time.  
Comparing a measure such as the mean BAI change over a period of time for an 
intervention group to the mean BAI change for a control group will indicate 
whether participation in an intervention has a different effect on quality of life 
than non-participation over the same time period.   
The easiest way to implement a control group for this type of study, where 
the patients constitute a convenience sample, is to create a randomized wait-list 
control group.  In this instance, because there were three different planned 
treatments, the control group could be created in the following manner: take the 
group of patients who want to enroll in meditation practice and randomly assign 
3/4 to the meditation group and 1/4 to the wait-list group; take the group of 
patients who want to enroll in yoga practice and randomly assign 3/4 to the yoga 
group and 1/4 to the wait-list group; similarly, take the patients who want to 
enroll in counseling and randomly assign 3/4 to the counseling group and 1/4 to 
the wait-list group.  Thus, there will be a total of 4 groups: 3 treatment groups and 
1 control group.  Patients should be randomly distributed in terms of demographic 
variables such as age or type of cancer.  See page A3 for a copy of the memo sent 
to the researchers at the HOS Foundation by the author, concerning these 
recommendations.   
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Revised Experimental Design 
 Based on the considerations presented above, the HOS Foundation has 
developed a revised study protocol.  The relevant details of the new protocol are 
summarized below, along with additional discussion of the revised protocol.   
 The primary goal of the revised study will be to determine the 
effectiveness of each of the intervention programs in improving the patients’ 
quality of life.  Secondary objectives will be to determine the effectiveness of 
each intervention program versus the others, to determine whether the 
effectiveness of intervention programs differs for patients receiving adjuvant or 
non-adjuvant chemotherapy (patients with early stage cancer or late-stage cancer), 
and to determine if any other correlations exist between demographic or clinical 
parameters and the effect of participation in intervention programs on patients’ 
quality of life.   
 The patient population consists of consecutive patients due to begin their 
prescribed chemotherapy and/or radiation therapy regimen after a diagnosis of 
cancer.  Prior to beginning therapy, patients will be given an information packet 
describing the wellness intervention programs available from the HOS 
Foundation and the plans to evaluate these programs in a scientific study.  All 
patients will have the option to participate in either the meditation group program 
or the yoga group program.  Certain patients may be referred for psychological 
counseling by their physician, oncology nurse, or social worker, or self-referred 
for symptoms of psychological distress.  Patients suffering from clinically evident 
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lymph edema may be referred for lymph edema therapy by their physician or 
oncology nurse.  Patients may choose not to participate in any intervention if that 
is their wish.  All patients, including those who do not wish to participate in an 
intervention program, will be asked to consent to participating in this study.  It is 
the patient’s right to refuse participation in the study without compromising the 
quality of treatments they will receive from the HOS Foundation or HOS 
physicians.   
The HOS Foundation originally wanted to include financial counseling as 
a group in this study; however, the author will advise against this.  Patients 
typically meet with a financial counselor for only one or a few sessions, not for 
six or 12 weeks, as the yoga, meditation, and personal counseling programs do.  
Also, the number of patients enrolled in the financial counseling program is much 
smaller than the number of patients participating in the yoga, meditation and 
personal counseling groups.  These were two reasons why the HOS Foundation 
had previously decided to exclude nutritional counseling and genetic counseling 
from the study.  Lymph edema management can be reasonably included in this 
study because lymph edema treatments, although based on individual patient 
need, are likely to last for at least six weeks, and probably for a long as the full 
12-week length of the study.  In addition to recruiting patients for the study who 
do not wish to participate in an intervention, the researchers will take the author’s 
advise and create a wait-list control group consisting of patients who are 
interested in participating in either the meditation or yoga programs.   
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 Thus, patients who consent to the study will be divided into the following 
treatment groups: (1) non-participation group: patients who do not want to 
participate in a wellness program; (2) wait-list group: patients who want to 
participate in either the meditation or yoga programs, who have been randomly 
assigned to the wait-list control group; (3) meditation group: patients who want to 
participate in the meditation program and have been randomly assigned to begin 
the program immediately; (4) yoga group: patients who want to participate in the 
yoga program and have been randomly assigned to begin the program 
immediately; (5) personal counseling group: patients who have been referred for 
psychological counseling; (6) lymph edema group: patients who have been 
referred for lymph edema treatment.   
All patients participating in the study will be asked to complete the QLQ-
C30 psychometric survey at three time points: just prior to beginning an 
intervention, six weeks after beginning the wellness intervention, and 12 weeks 
after beginning the wellness intervention.  One exception is that the wait-list 
group will complete the surveys at time 1, then begin the wellness program of 
their choice at time 2 (six weeks later), and then continue to complete the 
psychometric surveys at the regular time intervals, as it is felt that 12 weeks 
would be too long for patients to wait to begin an intervention.  In addition, the 
personal counseling group will complete BAI and BDI-II questionnaires at each 
time point, in order for therapists to monitor the anxiety and depression levels of 
their patients more closely.  Patients referred for lymph edema management will 
be continuously monitored by circumferential limb measurements, as is standard 
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for this type of therapy.  At any time, patients assigned to the non-participation or 
wait-list groups may immediately begin the appropriate intervention program if, 
in the opinion of the HOS staff, they would be harmed by undue delay. These 
patients should continue to complete the psychological questionnaires at the 
regular intervals, and, if possible, these data can be incorporated into the study.  
Clinical and demographic data will be obtained for each patient, according to 
HIPPA guidelines, and with patient consent.   
The EORTC QLQ-C30 was chosen as the main psychometric instrument 
for this study because it is widely accepted in oncology literature to be the “gold 
standard” of quality of life measurements for cancer patients [7,12,13].  The 
QLQ-C30 was developed by the European Organization for Research and 
Treatment of Cancer in order to specifically measure the global health status and 
overall quality of life (QoL), as well as several “functional scales” (e.g. social 
functioning, physical functioning), and several common symptoms of cancer and 
cancer therapies (e.g. fatigue, nausea); several supplementary modules are also 
available to measure symptoms associated with specific types of cancer (e.g. 
breast cancer, lung cancer).  The QLQ-C30 questionnaire is a popular choice for 
chemotherapy studies because of its efficiency; the questionnaire is only 30 
questions long, and yet it provides several different measurements of quality of 
life for cancer patients.  The QLQ-C30 has undergone extensive evaluation for 
internal validity reliability and is now in its 3rd version [5].  A higher number for 
global QoL and functional scales indicates a higher(better) level of QoL or 
functioning, while a higher number for symptoms scales represents a 
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higher(worse) level of symptoms.  See pages A5-A8 for a specimen of the QLQ-
C30 questionnaire and scoring instructions.   
 
Recommendations for Statistical Analysis 
 Unfortunately, the small amount of pilot data collected for this study did 
not allow for a very sophisticated statistical analysis.  In a study such as this, 
where there are several levels of treatments being tested simultaneously on a 
population defined by many characteristics, there are many types of statistical 
tools available to researchers.  If the researchers can properly collect the data from 
the full-scale study, the statistical analysis should be quite interesting.  Consider 
the data set on page B7; this is a completely fictitious data set which will merely 
serve as an example to illustrate the kinds of data and statistical procedures that 
may be appropriate to analyze when the study is complete.  See page B6 for the 
definitions of the variables used in the data set.  The following guideline for the 
statistical analysis for this study will focus on comparing the effectiveness of the 
different treatment groups by comparing the patients’ scores on the EORTC 
QLQ-C30.  Evaluation of the BAI and BDI-II scores collected from the 
counseling group and the limb measurements from the lymph edema therapy 
group would be analogous to the analysis done for the pilot data (one-sample, 
one-tailed t-tests).   
 The first step in any statistical analysis is always straightforward: describe 
the characteristics of the samples by calculating several univariate descriptive 
statistics, such as mean, median, variance, range etc.  In this case, the researchers 
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will want to describe the demographic and clinical parameters of the patient 
samples, both overall, for each treatment group, and for each type of 
chemotherapy.  The researchers will also want to summarize the scores from the 
QLQ-C30 at each time point, both overall, for each treatment group, and for each 
type of chemotherapy.  The final part of this descriptive analysis should be to 
define “percent change” variables, for example, %∆QoL(2-1) = (QoL2 – 
QoL1)/QoL1 is the percent change in quality of life from week 0 to week 6, and 
%∆SF(3-1) = (SF3 – SF1)/SF1 is the percent change in social functioning from 
week 0 to week 12.  Reporting the patients’ changes in quality of life in terms of 
percent change, rather than absolute change, will show the patients’ improvement 
relative to their initial QoL score before beginning an intervention.  This will be a 
more appropriate measure of improvement because patients will begin the study 
with widely varied QoL scores.  The researchers may decide to analyze all sub-
scores from the QLQ-C30 (see page A8), or choose specific items to evaluate, for 
example, testing improvement in functional scales, but not for physical 
symptoms.  Either way, the procedure for analyzing each sub-score will be 
exactly the same.   
The next step should be to analyze the data to test the researchers’ 
hypothesis that participation in a wellness intervention programs improves the 
quality of life for cancer patients.  Usually, in medical or psychological studies, 
statistical results are reported in terms of t-tests, regression equations, or ANOVA 
tables.  A one-sample t-test will show whether a sample’s mean is significantly 
different from zero, a two-sample t-test will show whether the means of two 
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different groups are significantly different from each other, and an ANOVA table 
will show whether the means of several groups are significantly different.  
Regression analysis can give a formula for predicting the value of one variable 
based on the value of other variables.   
These statistical tests are easy to evaluate and report; if the p-value 
associated with the test statistic (either t or F) is less than the α-level, then the null 
hypothesis, that the means are all equal or equal to zero, can be rejected.  
However, to actually compute all these tests individually is inefficient.  The 
ANOVA table is not difficult to compute, and a significant F statistic indicates 
that various two sample t-tests may further illuminate exactly which of the means 
of the treatment groups are actually different from each other.  However, selecting 
the parings for the tests and partitioning the data into the appropriate groups for 
each test is extremely tedious.  Regression analysis can also be laborious at times.  
For example, the QoL scores can be regressed against variables such as age, sex, 
race, cancer, chemo, etc. if the categorical variables are first modified by a 
process known as coding dummy variables.  A dummy variable takes the value 
one if the experimental unit exhibits that property, it takes the value zero 
otherwise.  For instance, the variable “sex” can be renamed “female”, and instead 
of a column of Fs and Ms, the column will contain 1s and 0s.  A much more 
efficient and elegant method for computing the exact same regression 
coefficients, F statistics, and t statistics as these separate procedures above is to 
evaluate a general linear statistical model (GLM).   
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The researchers are interested in the effects of each wellness program on 
the quality of life for the patients, but they are also interested to see if patients 
receiving adjuvant or non-adjuvant chemotherapy differ in their response to the 
wellness interventions.  There are six different types of interventions (four 
wellness programs and two “control” groups), and there are two levels of 
chemotherapy; thus, the experimental design for this study is a 6×2 factorial 
design.  However, there are also several variables which may also influence the 
patients’ quality of life measurements; the demographic and clinical variables to 
be recorded for each patient are: sex (male or female), age (≤ 50 years old or > 50 
years old), race (Asian, Black, Hispanic, White etc.) and type of cancer (breast, 
colon, leukemia, lung, ovarian, prostate etc.).  These variables should be included 
in the linear model as covariates.  Thus the GLM is: 
yijk = µ + β1(sexk) + β2(agek) + β3(racek) +β4(cancerk) + trtmnti + chemoj  
+ (trtmnt*chemo)ij + eijk; i = 1 to 6; j = 1 to 2; k = 1 to nk.   
Where yijk is the psychometric survey score (QoL, PF, EF etc.) for the kth patient 
in the ith treatment group with the jth type of chemotherapy; µ is the grand mean 
of survey scores for the entire patient sample; β1 is the coefficient of linear 
regression of y on the variable sex; β2 is the regression coefficient of y on age; β3 
is the regression coefficient of y on race; β4 is the regression coefficient of y on 
cancer; trtmnti is the fixed effect of treatment i; chemoj is the fixed effect of 
chemotherapy type j; (trtmnt*chemo)ij is the interaction effect between treatment i 
and chemotherapy type j; and eijk is the experimental error.   
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 In a model such as this, where the covariates are categorical variables, it 
may be helpful to think of them as different blocks and the effects that they 
produce on y as blocking effects; however, keep in mind that determining the 
regression coefficients will still be an important part of the analysis.  The 
researchers should pre-determine the linear contrasts, such as ‘non-participation 
vs. others’ or ‘non-traditional therapies vs. psychological counseling’, they wish 
to estimate and test.  An ANCOVA (Analysis of Covariance) of this model with 
the planned linear contrasts and solutions will automatically calculate all the F 
statistics, t statistics, and regression coefficients of interest.  The F statistic for 
each βr will show whether there is any significant correlation between survey 
scores and the demographic and clinical variables.  A two-way ANOVA of the 
response variable by the two factors of treatment and chemotherapy type is 
automatically imbedded in the ANCOVA.  The F-scores from the ANOVA will 
show whether there are any significant effects from the different treatments, from 
the two types of chemotherapy, or from any interaction between treatment and 
chemotherapy type.  The tests of linear contrasts calculate the t-scores for the 
differences between the various groupings of patients as decided by the 
researchers.  This ANCOVA procedure will give the same results as computing 
separate ANOVA tables, t-tests, and regression analysis, but it is much more 
efficient, especially with one of the many powerful statistical computing packages 
available.   
The same model can be applied with the response variable defined as one 
of the “change” variables; in general terms, yijk = (qijk(b) – qijk(a))/qijk(a).  The 
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ANCOVA for this model will show whether there are any significant regression 
coefficients.  The automatic ANOVA will show whether there are significant 
differences in the percent change in quality of life experienced by the cancer 
patients in the different treatment and chemotherapy groups.  Finally, the linear 
contrasts will show whether there is any difference in the percent change in 
quality of life between specific groups of patients.   
Finally, the researchers should use an a priori power analysis to estimate 
the number of patients to recruit for this study.  Recall the discussion of power 
from above (see page B3 for a further discussion).  The researchers need to decide 
how much of an improvement in quality of life scores represents a significant 
medical or psychological improvement: 10%, 20%, etc.  Then, using an estimate 
of the population variance, they can determine an estimate for the ideal sample 
size for each treatment group and overall.  Unfortunately, at the time this paper 
was written, the author did not have such an estimate of variation in order to 
conduct the a priori power analysis because the researchers did not use the 
EORTC QLQ-C30 to collect any of the pilot data.   
The researchers have two options: either collect more pilot data using the 
same psychometric instrument that they intend to use for the full-scale study, or 
search the relevant literature for a study that used the QLQ-C30 questionnaire on 
a similar population of patients and use the sample standard deviation reported in 
another study as an estimate of the population standard deviation.  There are 
advantages and disadvantages for each option.  Reviewing the literature would be 
less time consuming, but there is no guarantee that a suitable estimate of 
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population variance can be found.  Collecting more pilot data would be more 
costly, but the researchers could be more confident that the estimate of the 
variance calculated would be more accurate for the present patient population.   
The researchers should also be aware that some patients who begin the 
study may drop out before the study is complete.  Patients may be lost to follow-
up due to becoming too ill to participate in the programs or death.  Patients may 
also simply drop out of the program for personal reasons, such as moving out of 
the area or are not enjoying the programs offered.  In order to have a large enough 
sample for a powerful statistical analysis, the researchers should take these factors 
into consideration and overestimate the initial patient sample size to ensure that 
enough patients will complete the study.   
 
Conclusion 
 The HOS Foundation strives to provide the best possible services for HOS 
patients, and an integral part of these services are several psychosocial 
interventions, or “wellness programs,” aimed at helping cancer patients to cope 
with the physical and psychological stresses of their disease.  Non-traditional 
cancer therapies are becoming increasingly popular among patients, and research 
on the effects of these therapies features prominently in oncology literature.  The 
HOS Foundation plans to evaluate the effectiveness of their wellness programs in 
a scientific study and later publish an article with the results of this study.   
HOS Foundation first conducted a pilot study to collect some exploratory 
data.  The pilot data showed that participation in a meditation program 
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significantly reduced the symptoms of stress experienced by the patients (t = 2.70, 
p = 0.011), and that participation in psychological counseling significantly 
reduced the anxiety and depression levels of the patients (t = 5.33, p = 0.002; t = 
8.70, p < 0.001, respectively).  Based on the results of the pilot data, assessment 
of the original study protocol, and a review of the relevant psycho-oncology 
literature, the author has developed an extensive guideline for the experimental 
design and statistical analysis for the full-scale study.   
The HOS researchers are interested in determining the effects of six 
different treatment groups: non-participation, wait-list, yoga, meditation, 
psychological counseling, and lymph edema therapy, and two different types of 
chemotherapy: adjuvant and non-adjuvant, on the quality of life experienced by 
the HOS patients.  Thus, the design for this experiment is a 6×2 factorial design, 
with several possible covariates: age, cancer diagnosis, race, and sex.  
Researchers should use an ANCOVA and ANOVA with planned linear contrasts 
to test the general hypothesis that participation in an intervention increases the 
quality of life experienced by the patients.  Evaluation of a GLM will yield the 
same test statistics (F-scores, t-scores, and regression coefficients) as are 
commonly reported in medical and psychological journals; however, this 
procedure is much more efficient than performing many separate calculations.   
This study will be an important contribution to the body of oncology 
literature.  Many studies have reported on the benefits of various non-traditional 
cancer therapies; however, no study has yet to compare the effects of these types 
of wellness interventions to those of traditional psychological counseling.   
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